34.22 USD
↘ 0.25 (0.73%)AT CLOSE (11:59 AM EDT)
Indivior Pharmaceuticals, Inc. Common Stock
INDVNASDAQ • USD
34.25
↗ 0.03 (0.09%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
34.25
↗ 0.03 (0.09%)
Market: OPEN
INDV is currently priced at $34.25. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On the valuation side, INDV appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Sep 15, 2026.
Open?$34.59
High?$34.59
Low?$33.74
Prev. Close?$34.47
Volume?2.7M
Avg. Volume?2.4M
VWAP?$34.08
Rel. Volume?1.13x
Bid / Ask
Bid?$28.89 × 100
Ask?$40.06 × 100
Spread?$11.17
Midpoint?$34.48
Valuation & Ratios
Market Cap?4.1B
Shares Out?N/A
Float?109.8M
Float %?93.0%
P/E Ratio?11.46
P/B Ratio?-19.56
EPS?$3.01
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).
Employees
838
Market Cap
4.1B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2014-12-24
Address
10710 MIDLOTHIAN TURNPIKE
NORTH CHESTERFIELD, VA 23235
Phone: 804-379-1090
NORTH CHESTERFIELD, VA 23235
Phone: 804-379-1090
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?81
Momentum?88
Short Sent.?55
Piotroski F-Score?0/9Weak
Altman Z-Score?3.38Safe
Confidence?49%Low
Short InterestHigh
Short % of Float?10.29%High
Short Interest?11.3M
Days to Cover?5.7
Free Float109.8M
Avg Daily Volume2.0M
Settlement Date2026-08-31
Financial Health
Current Ratio?0.84Weak
Quick Ratio?0.66Weak
Cash Ratio?0.26Low
Debt/Equity?-2.34Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score87/100
P/E?11.5CHEAP▾
Peers100
S&P92
P/B?-19.56CHEAP▾
S&P97
P/S?3.05FAIR▾
Peers100
S&P50
P/FCF?N/A▾
EV/EBITDA?10.1CHEAP▾
Peers100
S&P81
EV/Sales?3.25FAIR▾
Peers100
S&P57
Returns & Efficiency
ROE?-170.7%WEAK▾
S&P3
ROA?28.8%STRONG▾
Peers50
S&P97
Cash Flow & Enterprise
FCF?$-111000000
Enterprise Value?$4.3B
Fundamentals ratios updated end of day